Filing Details

Accession Number:
0001127602-20-005716
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-14 17:10:04
Reporting Period:
2020-02-14
Accepted Time:
2020-02-14 17:10:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1198092 F Richard Wallman Charles River Laboratories
251 Ballardvale Street
Wilmington MA 01887
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-14 3,530 $52.29 32,897 No 4 M Direct
Common Stock Disposition 2020-02-14 3,530 $174.29 29,367 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2020-02-14 3,530 $0.00 3,530 $52.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-05-07 2021-05-07 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $174.25 to $174.39. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.